Patents by Inventor David Frederick Callen

David Frederick Callen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7556920
    Abstract: An isolated nucleic acid molecule mapping to chromosome 16q24.3 and comprising the nucleotide sequence set forth in SEQ ID Numbers: 1 or 3.
    Type: Grant
    Filed: May 15, 2006
    Date of Patent: July 7, 2009
    Assignee: Bionomics Limited
    Inventors: David Frederick Callen, Jason Powell, Gabriel Kremmidiotis, Alison Gardner, Joanna Crawford, Anthony Bais, Marina Kochetkova
  • Patent number: 7083927
    Abstract: An isolated nucleic acid molecule mapping to chromosome 16q24.3 and comprising the nucleotide sequence set forth in SEQ ID Numbers: 1 or 3.
    Type: Grant
    Filed: January 31, 2002
    Date of Patent: August 1, 2006
    Assignee: Bionomics Limited
    Inventors: David Frederick Callen, Jason Powell, Gabriel Kremmidiotis, Alison Gardner, Joanna Crawford, Anthony Bais, Marina Kochetkova
  • Publication number: 20040170994
    Abstract: A method for the diagnosis of a predisposition thereto, in a patient, comprising the steps of: (1) establishing the level of expression of a gene selected from the group consisting of PR domain containing 7 protein (PRDM7), CDT1 DNA replication factor (CDT1), charged multivesicular body protein 1/chromoatin modifying protein 1 (CHMP1), BTG3 associated nucleoprotein (BANP), BNO224, BNO36, BNO34, BNO208, BNO230 and BNO44; and (2) comparing expression of the gene to a baseline established from expression in normal tissue controls; wherein substantial variance from the baseline indicates that the patient is susceptible to cancer.
    Type: Application
    Filed: August 7, 2003
    Publication date: September 2, 2004
    Inventors: David Frederick Callen, Gabriel Kremmidiotis, Scott Whitmore, Alison Gardner, Jason Powell